Venkys (India) LtdQ1 FY25Food Products

Venkys (India) Ltd

Q1 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Poultry segment is expected to grow 5%-10% in volume for FY '26 with improved realizations.
→Animal Health (AHP) segment targets around 15%-20% growth; INR 340 crores revenue expected in FY '25 with 15% growth guidance for FY '26.
→Expansion in SPF eggs capacity by 40,000 bird placements ongoing; potential for increased output if demand materializes.
→Processed food (ready-to-eat/cook) segment growth projected at 25%-30% next year.
→Soybean segment expects about 25% growth after degrowth last year.
→New products and export initiatives underway to drive consistent and futuristic growth.
→Marketing spends focused on quick commerce and e-commerce channels to fuel processed product sales growth.
→Margin improvements expected with new capacities and processing plants stabilizing in Animal Health and other divisions.

Margin guidance

Category 3

→Poultry segment revenue expected to grow by around 5% to 10% in FY '26 with better realization anticipated (Vijay Tijare, Page 7).
→Animal Health segment projected to grow at approximately 20% in FY '26, building on consistent past growth (Deepak Khosla, Pages 7, 18).
→Oilseed segment profitability expected to improve with stable soya prices; however, not likely to reach past peak EBIT levels (J.K. Handa, Page 13).
→SPF egg production expansion (INR 70 crores capex) underway, with capacity utilization currently at 60-65%, expected to enhance future earnings but takes about 2 years to fully contribute (J.K. Handa, Pages 11-12).
→Ready-to-eat and ready-to-cook segments (retail and QSR) currently ~10% of poultry revenue and expected to grow by 25-30%, with Animal Health also contributing ~10%, providing pricing power and margin stability (Page 17).
→Overall optimistic outlook with stable commodity prices and capacity expansions supporting moderate growth in operating earnings and profits.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Venkys (India) Ltd and 1,400+ other companies.

Fundraise plans

→There is no explicit mention of any current or planned new fundraising through debt or equity in the provided transcript.
→The company has ongoing capital expenditure plans, such as the INR 70 crore expansion for SPF capacity and new plant commissioning for the Animal Health segment.
→Existing capital expenditure is funded internally, with no direct reference to raising funds via debt or equity.
→The company appears focused on capacity expansion, product innovation, and improving utilization, financed through operational cash flows.
→No queries or answers during the call highlight intentions for new fundraising activities.

Order book

- The transcript does not provide explicit details on the current or expected order book or pending orders for Venky's (India) Limited. - However, there is an indication that the company is optimistic about growth in various segments like Animal Health (AHP), ready-to-cook/ready-to-eat processed foods, and exports. - New product innovations and expansion (e.g., SPF egg capacity, processed food division) suggest an expected positive order inflow. - The company launched new product lines and markets through QSR, retail, and e-commerce, expecting 25-30% sales growth next year. - For the SPF egg production, capacity is at 188 lakh eggs with 40,000 bird placements under expansion, implying potential order increases as demand rises. - Overall, production and sales growth guidance for FY 2025-26 is optimistic, with segments like AHP expecting ~15% growth. *No specific numeric order backlog values are mentioned in the document.*

Capex plans

Yes

→INR 70 crores capex planned for SPF (Specific Pathogen Free) egg expansion; expected to complete in about 1 year and take 2 years to reach full production. Current SPF capacity utilization is 60-65%; expansion will add capacity of around 40,000 birds annually.
→New animal health plant commissioned recently, operating at 55-60% capacity; exploring new product lines, expected to improve margins and contribute to 20% revenue growth in AHP segment for FY '26.
→Strategic initiatives include starting production of ready-to-cook spices in the next quarter, targeting both local and export markets with authentic Indian taste products.
→Focus on stable commodity prices (especially soya) to control production costs; maize price outlook uncertain and affects broiler hatching egg production costs.
→Capacity expansions complemented by regulatory clearances and expected sustainable, respectable growth in coming years.

How does Venkys (India) Ltd rank vs peers in Food Products?

Pro feature

1Venkys (India) Ltd

Rev 3Mar 3

See full Food Products sector rankings

Unlock with Pro

Want more stocks like Venkys (India) Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio